Cellevat3d® for iPSC

About Cellevate

Cellevate is a privately held biotech company based in Lund, Sweden, founded in 2015 as a spin-out from Lund University. The company has developed the Cellevat3d® platform, a proprietary, cellulose-based nanofiber technology that serves as a microcarrier for high-density cell culture in bioreactors. Its primary value proposition is driving >10-fold increases in viral vaccine and vector yields while offering scalability, sustainability, and process simplification. Cellevate is ISO 9001:2015 certified, employs GMP processes, and is transitioning from R&D to early commercialization with its first products for viral vaccine and lentiviral vector production.